C20orf117 Activators are a diverse array of chemical compounds that facilitate the enhancement of the C20orf117 protein's functional activity through various cellular signaling pathways. Agents such as Forskolin and Isoproterenol raise intracellular cAMP levels, which in turn activate PKA, possibly leading to the phosphorylation and subsequent activation of C20orf117 if it is a target of PKA. Similarly, EGCG, by inhibiting tyrosine kinases,C20orf117 Activators encompass a range of chemical compounds that indirectly amplify the functional activity of C20orf117 by interfacing with specific intracellular signaling cascades. Forskolin and Isoproterenol, by hiking cAMP levels, indirectly buttress C20orf117's activity by activating protein kinase A (PKA), which may phosphorylate and activate C20orf117 assuming it is a PKA substrate. The calcium ionophores, Ionomycin and A23187, bolster intracellular calcium, which could stimulate calcium-sensitive kinases to enhance C20orf117 activity, provided that it is calcium-regulated. Conversely, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), potentially escalating C20orf117 activity if it is within the PKC signaling realm. Epigallocatechin gallate (EGCG), through tyrosine kinase inhibition, and LY294002, by impeding PI3K, can amplify C20orf117 activity by tempering competitive or negative regulatory signaling.
The modulation of C20orf117 activity is further facilitated by the manipulation of the MAPK pathway; U0126 and SB203580, by hindering MEK1/2 and p38 MAPK respectively, could lift the suppression of C20orf117, presuming it is negatively influenced by these kinases. In the realms of cGMP and calcium signaling, Sildenafil and Thapsigargin emerge as putative activators by enhancing cGMP levels and obstructing the SERCA, respectively, thus promoting the functional activity of C20orf117 if it is sensitive to these pathways. Tetrodotoxin's blockade of voltage-gated sodium channels might also indirectly influence C20orf117 activity, particularly if C20orf117 operates within neuronal signaling frameworks. Collectively, these chemical entities, through their targeted action on various biochemical pathways, facilitate the activation of C20orf117 without necessitating the upregulation of its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular calcium levels, which could activate calmodulin-dependent kinases or other calcium-sensitive enzymes that subsequently enhance the activity of C20orf117 if it is regulated by calcium signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) and could enhance C20orf117 activity if C20orf117 is downstream of or regulated by PKC signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain tyrosine kinases, potentially altering signaling pathways and enhancing the activity of C20orf117 if it is influenced by tyrosine kinase activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can modulate PI3K/Akt signaling. If C20orf117 is negatively regulated by this pathway, inhibition by LY294002 could result in enhanced activity of C20orf117. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAPK. If C20orf117 activity is negatively influenced by p38 MAPK, inhibition by SB203580 could lead to increased activity of C20orf117. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore, like Ionomycin, and increases intracellular calcium, potentially enhancing C20orf117 activity through calcium-dependent pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to increased intracellular calcium levels. If C20orf117 is modulated by calcium, Thapsigargin could enhance its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP levels, potentially enhancing C20orf117 if it is modulated by cAMP or downstream effectors such as PKA. | ||||||